Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Mar. 31, 2026
Current assets    
Cash, cash equivalents, and restricted cash $ 51,620 $ 37,960
Accounts receivable, net 266,404 251,240
Prepaid expenses 4,868 6,060
Value-added tax receivable 3,361 4,461
Other current assets 17,233 12,149
Total current assets 343,486 311,870
Property and equipment, net 49,363 49,111
Right-of-use assets 7,222 7,739
Intangible assets, net 199,447 217,448
Goodwill 222,725 223,053
Other non-current assets 22,541 32,433
TOTAL ASSETS 844,784 841,654
Current liabilities    
Accounts payable 127,952 129,491
Accrued revenue share 107,252 95,116
Accrued compensation 12,989 22,408
Acquisition purchase price liabilities 436 436
Current portion of long-term debt 9,375 7,031
Other current liabilities 16,596 14,671
Total current liabilities 274,600 269,153
Long-term debt, net 344,230 353,932
Derivative liabilities 10,770 2,164
Deferred tax liabilities, net 13,465 15,818
Other non-current liabilities 4,833 4,838
Total liabilities 647,898 645,905
Commitments and contingencies (Note 13)
Stockholders’ equity    
Series A convertible preferred stock, $0.0001 par value; 2,000,000 shares authorized, 100,000 issued and outstanding (liquidation preference of $1) 100 100
Common stock, $0.0001 par value: 200,000,000 shares authorized; 122,479,980 issued and 121,721,855 outstanding at September 30, 2026; 121,073,328 issued and 120,315,203 outstanding at March 31, 2026 10 10
Additional paid-in capital 975,020 969,062
Treasury stock, (758,125 shares at September 30, 2026, and March 31, 2026) (71) (71)
Accumulated other comprehensive loss (53,606) (51,766)
Accumulated deficit (724,567) (721,586)
Total stockholders’ equity 196,886 195,749
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 844,784 $ 841,654